You are here

  • Home
  • Archive
  • Volume 76, Issue 1
  • Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study

Article metrics

Article menu

Download PDFPDF

Clinical and epidemiological research
Extended report
Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study

 

Online download statistics by month:

Online download statistics by month: June 2016 to March 2024

AbstractFullPdf
Jun 2016505318130
Jul 201619713066
Aug 2016883841
Sep 2016677437
Oct 2016926440
Nov 2016887871
Dec 2016832134200
Jan 201756794137
Feb 2017474840
Mar 2017107742
Apr 201726434
May 201747927
Jun 2017175334
Jul 2017514820
Aug 20176352115
Sep 2017675724
Oct 2017585613
Nov 2017937934
Dec 2017484220
Jan 2018858132
Feb 2018595033
Mar 2018574214
Apr 2018826729
May 2018938322
Jun 2018797321
Jul 2018605618
Aug 201831298
Sep 2018363618
Oct 2018383820
Nov 2018636127
Dec 2018524419
Jan 2019858329
Feb 2019645929
Mar 2019656330
Apr 2019817923
May 2019605932
Jun 2019454515
Jul 2019716927
Aug 2019483935
Sep 2019534720
Oct 2019594830
Nov 2019504220
Dec 2019686322
Jan 2020615220
Feb 2020685922
Mar 202012611533
Apr 2020403715
May 2020414115
Jun 2020353513
Jul 202036349
Aug 2020242118
Sep 2020464220
Oct 2020292925
Nov 2020434119
Dec 2020636310
Jan 2021454311
Feb 2021403821
Mar 2021636235
Apr 2021212112
May 2021434315
Jun 202136368
Jul 2021262623
Aug 2021191821
Sep 2021343121
Oct 202119418136
Nov 202134532631
Dec 202117216312
Jan 202253459
Feb 202261578
Mar 2022726014
Apr 2022677216
May 2022655617
Jun 2022564616
Jul 202226224
Aug 2022484811
Sep 2022464213
Oct 2022403616
Nov 2022444017
Dec 2022312515
Jan 2023515019
Feb 202359478
Mar 2023555213
Apr 2023553825
May 2023422817
Jun 2023403015
Jul 2023322714
Aug 2023322614
Sep 2023525020
Oct 20231461438
Nov 20232642615
Dec 2023584711
Jan 2024442612
Feb 2024898513
Mar 2024484419
Total770660012532